Publications

Found 29 results

Sort by: Author Title Type [ Year  (Desc)]
2022
2021
2020
Mundo L, Porro LD, Granai M, Siciliano MC, Mancini V, Santi R, Marcar L, Vrzalikova K, Vergoni F, Stefano GD, Schivoni G, Segreto G, Noel Onyango, Nyagol JA, Amato T, Bellan C, Anagnostopoulos I, Falini B, Leoncini L, Lazzi S. "Correction: Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas." Modern Pathology. 2020:10.1038/s41379-020-0608-y.
M G, L M, AU A, MC S, H R, V M, N O, J N, OA A, I M, S M, W W, M B, PP P, L Q-M, F F, S L, Leoncini L, T M. "Correction: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. ." Infect Agent & Cancer . 2020;15(39):doi:10.1186/s13027-020-00304-9.
Mundo L, Porro LD, Granai M, Siciliano MC, Mancini V, Santi R, Marcar L, Vrzalikova K, Vergoni F, Stefano GD, Schivoni G, Segreto G, Noel Onyango, Nyagol JA, Amato T, Bellan C, Anagnostopoulos I, Falini B, Leoncini L, Lazzi S. "Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas." Modern Pathology . 2020.
M G, L M, AU A, MC S, H R, V M, N O, J N, OA A, I M, S M, W W, M B, PP P, L Q-M, F F, S L, Leoncini L, T M. "Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. ." Infectious Agents & Cancer . 2020;15(28).
2019
M M, LZ M, J F, GM E, E R, R N, J T, DH M, J N, F W, AK B, M B, JG. O. "Kaposi Sarcoma-associated Herpesvirus Glycoprotein H is Indispensable for Infection of Epithelial, Endothelial, and Fibroblast Cell Types. ." J Virol. . 2019;93(16).
Mundo L, Ambrosio M, Raimondi F, Porro LD, Granai M, Mancini V, Guazzo R, Rocca B, Lopez C, Bens S, Noel Onyango, Joshua Nyagol, Abinya N, Navari M, Ndede I, Patel K, Piccaluga PP, Bob R, Santi MD, Russel R, Lazzi S, Siebert R, Stein H, Leoncini L. "Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases." Blood Cancer Journal. . 2019;9(91):2-10.
2018
2017
2016
2015
EK R, J N, J O, S N, N O, A O, CJ S, G B, WC C, B O, B E. "The effects of HIV-1 infection on malaria parasitemia in milo sub-location, western Kenya." BMC Res Notes.. 2015;8:303.
2014
A M, J N, Rogena E, W O, Kimani M, N O, L P, R S, Leoncini L, W M. "Correlation of EGFR, pEGFR and p16INK4 expressions and high-risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva." Infect Agent Cancer. . 2014;9(1):7.
2013
Nyagol J, Kisato V, Ochuk W, Wakio M. "Assessment of hormonal receptors and Her-2/neu status in breast cancer using cell block: a case study. ." J. Afr. Cancer.. 2013;5:180-184.
2011
Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, Falco DG, Githanga J, Horn H, Nyagol J, Ott G, Palatini J, Pfreundschuh M, Rogena E, Rosenwald A, Siebert R, Croce CM, Stein H. "The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma." Leukemia. 2011:1-8.
2010
E L, A O, M C, V C, G C, S M, R C, J N, W M, R I, K S, C B, Leoncini L. "B cell differentiation in EBV-positive Burkitt Lymphoma is impaired at post-transcriptional level by miRNA altered expression. ." Int J. Cancer.. 2010;126(6):1316-26.
2008
E L, M C, A O, van P C, C B, van A R, G DF, J N, B B, S L, P T, van J K, Leoncini L. "MYC-negative classical Burkitt’s Lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation." J Pathol. . 2008;216(4):440-50.
Falco DG, Cerino G, Leucci E, Nyagol J, Cocco M, Onnis A, Tosi P, Giordano A, Leoncini L. "Role of chromatin remodelling mediated by the HIV-1 Tat protein in the genesis of the HIV-1-associated malignancies." Virchows Archives. 2008;452(S43).
2007
Leucci E, Cocco M, Cleef PV, Bellan C, Rijik AV, Falco GD, Onnis A, Joshua Nyagol, Byakika B, Lazzi S, Tosi P, Kricken HV, Leoncini L. "Altered expression of mirnas in c-MYC negative Burkitt lymphoma cases." Virchows Archives. 2007;451(2):119.
G DF, E L, D L, PP P, PP C, A O, G C, J N, W M, C B, M H, S P, P T, H S, A G, Leoncini L. "Gene expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt's lymphoma cell lines and primary tumors." Blood.. 2007;110(4):1301-7.
J. N. Oncogenic and Angiogenic Roles of HIV-1 Tat Protein. Siena, Italy: PhD Thesis, University of Siena; 2007.
2006
J N, E L, A O, G DF, C T, F S, M T, N P, L P, R S, D S, P G, L M, S L, F P, Leoncini L, A G. "The Effects of HIV-1 Tat Protein on Cell Cycle during Cervical Carcinogenesis." Cancer Biol Ther. . 2006;5(6):684-90.
J N, A N’o, B B, L M, M C, de MM S, D S, C B, S L, I K, P L, Leoncini L. "Routine assessment of hormonal receptor and Her-2/neu status underscores the need for more therapeutic targets in Kenyan women with breast cancer." J. of AQCH . 2006;28(2):97-103.
2005
C B, S L, M H, N P, de M S, T A, J N, E S, T L, SA P, M R, H S, P T, Leoncini L. "Immunoglobulin gene analysis reveals two distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas." Blood. 2005;106(3):1031-6.

UoN Websites Search